TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy

Tanjing Song1, Suli Lv2, Xianyun Ma2

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Cell Architecture Research Institute, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Insights

The TRIM28-TFE3-KDM6A pathway regulates kidney cancer cell growth by controlling autophagy. TRIM28 inhibits TFE3, a key factor in autophagic gene expression, thus slowing cancer proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Autophagy is crucial in cancer, but its dysregulation mechanisms are unclear.
  • TRIM28 loss is linked to kidney cancer, yet its role is not fully understood.
  • TFE3 gene fusions cause kidney cancer, but TFE3's broader role in chromatin regulation needs clarification.

Purpose of the Study:

  • To elucidate the mechanism by which TRIM28 influences kidney cancer.
  • To investigate the role of TFE3 and KDM6A in kidney cancer cell proliferation and autophagy.
  • To identify key signaling pathways regulating kidney cancer progression.

Main Methods:

  • Investigated TRIM28's effect on autophagy and kidney cancer cell proliferation.
  • Analyzed TRIM28-mediated ubiquitination and degradation of TFE3.
  • Examined TFE3 nuclear localization and its interaction with KDM6A in kidney cancer cells.
  • Assessed the impact of KDM6A on histone modifications and gene expression.

Main Results:

  • TRIM28 inhibits kidney cancer cell proliferation by suppressing autophagy.
  • TRIM28 promotes TFE3 degradation, a transcription factor essential for autophagic gene expression.
  • TFE3 is constitutively nuclear in kidney cancer, upregulating autophagic genes and promoting proliferation.
  • TFE3 recruits KDM6A to enhance autophagic gene expression via H3K4me3 modification, not H3K27 demethylation.

Conclusions:

  • Identified a TRIM28-TFE3-KDM6A signaling axis critical for kidney cancer.
  • TRIM28 acts as a tumor suppressor by inhibiting autophagy through TFE3 degradation.
  • TFE3 and KDM6A promote kidney cancer cell autophagy and proliferation via epigenetic modifications.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K